NASDAQ: LNSR
Lensar Inc Stock

$7.70+0.44 (+6.06%)
Updated Dec 6, 2024
LNSR Price
$7.70
Fair Value Price
N/A
Market Cap
$89.43M
52 Week Low
$2.12
52 Week High
$8.17
P/E
-5.27x
P/B
3.93x
P/S
1.09x
PEG
N/A
Dividend Yield
N/A
Revenue
$48.87M
Earnings
-$16.61M
Gross Margin
48.9%
Operating Margin
-34%
Profit Margin
-34%
Debt to Equity
1.12
Operating Cash Flow
-$6M
Beta
0.43
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

LNSR Overview

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine LNSR's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

C
Value
A
Growth
B
Momentum
C
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
D
LNSR
Ranked
#21 of 127

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$28.71A
$11.68A
$49.71A
View Top Medical Device Stocks

Be the first to know about important LNSR news, forecast changes, insider trades & much more!

LNSR News

Overview

Due Diligence Score

–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how LNSR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

LNSR is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
LNSR is good value based on its book value relative to its share price (3.93x), compared to the US Medical Devices industry average (4.05x)
P/B vs Industry Valuation
LNSR is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more LNSR due diligence checks available for Premium users.

Valuation

LNSR price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-5.27x
Industry
36.83x
Market
29.86x

LNSR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
3.93x
Industry
4.05x
LNSR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

LNSR's financial health

Profit margin

Revenue
$13.5M
Net Income
-$1.5M
Profit Margin
-10.9%
LNSR's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
LNSR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$62.0M
Liabilities
$25.5M
Debt to equity
1.12
LNSR's short-term assets ($39.40M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LNSR's short-term assets ($39.40M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LNSR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$3.2M
Investing
-$905.0k
Financing
-$93.0k
LNSR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

LNSR vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
LNSRB$89.43M+6.06%-5.27x3.93x
RBOTF$95.06M+8.06%-1.56x1.64x
NSPRC$79.82M+1.66%-4.25x1.93x
MASSF$79.74M-2.14%-1.29x0.61x
ECORC$77.93M+7.31%-6.72x8.24x

Lensar Stock FAQ

What is Lensar's quote symbol?

(NASDAQ: LNSR) Lensar trades on the NASDAQ under the ticker symbol LNSR. Lensar stock quotes can also be displayed as NASDAQ: LNSR.

If you're new to stock investing, here's how to buy Lensar stock.

What is the 52 week high and low for Lensar (NASDAQ: LNSR)?

(NASDAQ: LNSR) Lensar's 52-week high was $8.17, and its 52-week low was $2.12. It is currently -5.75% from its 52-week high and 263.21% from its 52-week low.

How much is Lensar stock worth today?

(NASDAQ: LNSR) Lensar currently has 11,614,807 outstanding shares. With Lensar stock trading at $7.70 per share, the total value of Lensar stock (market capitalization) is $89.43M.

Lensar stock was originally listed at a price of $12.20 in Oct 5, 2020. If you had invested in Lensar stock at $12.20, your return over the last 4 years would have been -36.89%, for an annualized return of -10.87% (not including any dividends or dividend reinvestments).

How much is Lensar's stock price per share?

(NASDAQ: LNSR) Lensar stock price per share is $7.70 today (as of Dec 6, 2024).

What is Lensar's Market Cap?

(NASDAQ: LNSR) Lensar's market cap is $89.43M, as of Dec 7, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Lensar's market cap is calculated by multiplying LNSR's current stock price of $7.70 by LNSR's total outstanding shares of 11,614,807.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.